PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $236,000 | -59.5% | 3,367 | -65.3% | 0.00% | -66.7% |
| Q4 2020 | $582,000 | -29.9% | 9,703 | -60.8% | 0.00% | -50.0% |
| Q1 2020 | $830,000 | -81.0% | 24,752 | -74.4% | 0.01% | -71.4% |
| Q4 2019 | $4,373,000 | +61.8% | 96,525 | +36.0% | 0.02% | +40.0% |
| Q3 2019 | $2,703,000 | -58.0% | 70,996 | -58.1% | 0.02% | -34.8% |
| Q1 2019 | $6,442,000 | +517.0% | 169,248 | +419.6% | 0.02% | +283.3% |
| Q2 2018 | $1,044,000 | -51.6% | 32,571 | -53.0% | 0.01% | -45.5% |
| Q1 2018 | $2,159,000 | -33.9% | 69,318 | -3.2% | 0.01% | -38.9% |
| Q4 2017 | $3,268,000 | +474.3% | 71,598 | +378.1% | 0.02% | +350.0% |
| Q3 2017 | $569,000 | -58.0% | 14,975 | -46.9% | 0.00% | -60.0% |
| Q2 2017 | $1,355,000 | – | 28,214 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |